Latest from Robert O'Harrow Jr.

The rise of domestic extremism in America

Data shows a surge in homegrown attacks not seen in a quarter-century.
  • Apr 12, 2021

Rallies ahead of Capitol riot were planned by established Washington insiders

Described as a grass-roots uprising, the Jan. 6 storming of the Capitol followed events planned by establishment Republicans and their activist allies.
  • Jan 17, 2021

Where Republicans in Congress stand on Trump’s false claim of winning the election

The Washington Post asked Republicans in Congress three questions. Who won the presidential election? Where do you stand on Trump's efforts to claim victory? Will you accept Joe Biden as the legitimately elected president? Here's what they said.
  • Dec 15, 2020

Kenosha: How two men’s paths crossed in an encounter that has divided the nation

In an exclusive interview, Kyle Rittenhouse said he bought a gun with stimulus money. The first man he shot had just left a psychiatric hospital.
  • Nov 19, 2020

‘I shot two White kids’: Records detail Kyle Rittenhouse’s surrender to police, origin of gun

Rittenhouse's attorneys have vowed an immediate appeal.
  • Oct 30, 2020

Videos show closed-door sessions of leading conservative activists: ‘Be not afraid of the accusations that you’re a voter suppressor’

The footage, covering dozens of hours of Council for National Policy meetings in February and in August, offers an inside view of the group’s obsessions, fears and plans at a pivotal moment in the conservative movement.
  • Oct 14, 2020

White House physician Sean Conley draws scrutiny for rosy assessments of Trump’s health

Long before the president contracted covid-19, some former colleagues said they were disappointed in what they view as his lack of independence from White House politics.
  • Oct 7, 2020

Trump said solving the opioid crisis was a top priority. His drug office’s track record suggests otherwise.

Trump has run the office much the way he has approached governance in general, showing skepticism, ambivalence and a lack of focus according to government audits, documents and drug policy specialists.
  • Oct 3, 2020

Before the pandemic, top contractor received billions from government to help prepare the nation for biowarfare

Emergent BioSolutions is the only maker of multiple drugs the government deems crucial for the Strategic National Stockpile, and the government is the company’s primary customer, accounting for most of its revenue.
  • Jun 17, 2020

Before pandemic, Trump’s stockpile chief put focus on biodefense. An old client benefited.

Robert Kadlec’s office at HHS made a deal to buy up to $2.8 billion of smallpox vaccine from a company that once paid him as a consultant, a connection he did not disclose on a Senate questionnaire when he was nominated.
  • May 4, 2020